Add to ORKGRecently, multiple breast cancer susceptibility loci have been iden-tified by several genome-wide association studies (GWAS) or studies of specific candidate single-nucleotide polymorphisms (SNPs) (1–10). Genetic variants that showed strong statistically significant associations with breast cancer risk (odds ratios [ORs] = 1.15–1.45, P < 5 × 1027) were identified in fibroblast growth factor receptor 2 (FGFR2). The vicinity is referred to all genes, not only FGFR2. In other words, some of the SNPs mentioned in this para-graph are located directly within the mentioned genes, some others are near the genes. TOX high mobility group box family member 3 (TOX3; also known as TNRC9), mitogen-activated protein kinase kinase kinase 1 (MAP3K1), cas...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
PURPOSE: Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in part...
PURPOSE: Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in part...
Background: Recently, several genome-wide association studies have identified various genetic suscep...
Contains fulltext : 89415.pdf (publisher's version ) (Closed access)Recent studies...
Contains fulltext : 81601.pdf (publisher's version ) (Closed access)Genome-wide as...
Background: Recently, several genome-wide association studies have identified various genetic suscep...
Contains fulltext : 70697.pdf (publisher's version ) (Closed access)Germline mutat...
Background: BRCA1 and BRCA2 mutation carriers have a lifetime breast cancer risk of 40 % to 80%, sug...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: BRCA1 and BRCA2 mutation carriers have a lifetime breast cancer risk of 40 % to 80%, sug...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
Background Recently, several genome-wide association studies have identified various genetic suscept...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
PURPOSE: Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in part...
PURPOSE: Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in part...
Background: Recently, several genome-wide association studies have identified various genetic suscep...
Contains fulltext : 89415.pdf (publisher's version ) (Closed access)Recent studies...
Contains fulltext : 81601.pdf (publisher's version ) (Closed access)Genome-wide as...
Background: Recently, several genome-wide association studies have identified various genetic suscep...
Contains fulltext : 70697.pdf (publisher's version ) (Closed access)Germline mutat...
Background: BRCA1 and BRCA2 mutation carriers have a lifetime breast cancer risk of 40 % to 80%, sug...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: BRCA1 and BRCA2 mutation carriers have a lifetime breast cancer risk of 40 % to 80%, sug...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
Background Recently, several genome-wide association studies have identified various genetic suscept...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
Introduction: Several common breast cancer genetic susceptibility variants have recently been identi...
PURPOSE: Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in part...
PURPOSE: Cis-acting regulatory SNPs resulting in differential allelic expression (DAE) may, in part...